Biomatter
biomatter.ai
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Biomatter designs industrial enzymes using generative artificial intelligence combined with synthetic biology laboratory work. Founded in 2018 in Vilnius, its Intelligent Architecture platform creates protein sequences that do not exist in nature. The company partners with chemical and consumer goods manufacturers on greener processes.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Biomatter joins AstraZeneca BioVentureHub
January 21, 2026 - We are thrilled to announce that Biomatter has officially joined the AstraZeneca BioVentureHub, marking a significant milestone as the first Baltic and Lithuanian company to enter this unique industrial R&D ecosystem based in Gothenburg
Read more
Report
Biomatter Establishes Relationship with Neogen
August 11, 2025 - Biomatter, a leading enzyme design company, enters into an arrangement with Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, to leverage Biomatter's proprietary Intelligent Architecture platform and Neoge
Read more
Report
Neogen Partners With Biomatter To Develop Advanced Enzyme-Based Food Safety Solutions
(RTTNews) - Neogen Corporation (NEOG) has entered into a partnership with enzyme design company Biomatter to develop innovative enzyme-based products for food safety applications.
Read more
Report
Neogen Establishes Relationship with Biomatter
LANSING, Mich., August 11, 2025--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that it has entered into an arrangement with Biomatter, a leading enzyme design company, to leverage Biomatter's proprietary
Read more
Report
Neogen Establishes Relationship with Biomatter
Detailed price information for Neogen Corp (NEOG-Q) from The Globe and Mail including charting and trades.
Read more
Report
AI-designed enzymes for health and sustainable manufacturing: Biomatter team in top 10 innovators of the Young Inventors Prize 2025
Enzymes are essential in many industrial advances nowadays, but conventional design methods often limit their potential Laurynas Karpus, Vykintas Jauniškis and Irmantas Rokaitis together with Donatas Repečka and Rolandas Meškys have developed an AI-powere
Read more
Report
Biomatter raises seed round for AI enzyme design
Chemical & Engineering News (C&EN): Keeping you up to date with the chemistry news that matters most. Published by the American Chemical Society.
Read more
Report
Biomatter raises a €6.5 million seed round to unlock the power of generative AI for enzyme design
Read more
Report
Breaking Nature's Limits: Enzyme Design for a Sustainable Future Powered by Intelligent Architecture
By redefining the fundamental structures and functions of enzymes, Biomatter is pushing the boundaries of biotechnology to meet global sustainability goals and transform industries. The growing demand for new enzymes is catalyzing the evolution of industr
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Vilnius
Lithuania
HQ
10-50 est. staff